Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies

Ann Rheum Dis. 1989 Mar;48(3):232-5. doi: 10.1136/ard.48.3.232.

Abstract

Procainamide is the commonest cause of a drug induced lupus syndrome. Long term administration of this compound may induce a variety of immunological abnormalities, including antinuclear antibodies. Uncommonly, 'lupus anticoagulants' have been demonstrated in the absence of other evidence of drug induced lupus. Details of a 67 year old man who developed not only drug induced lupus but also antiphospholipid antibodies which were associated with multiple pulmonary thromboemboli after the administration of procainamide are recorded.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoantibodies / analysis*
  • Blood Coagulation Factors / analysis
  • Blood Coagulation Factors / immunology
  • Cardiolipins / immunology*
  • Humans
  • Lupus Coagulation Inhibitor
  • Lupus Erythematosus, Systemic / chemically induced*
  • Lupus Erythematosus, Systemic / complications
  • Male
  • Procainamide / adverse effects*
  • Pulmonary Embolism / etiology*
  • Pulmonary Embolism / immunology

Substances

  • Autoantibodies
  • Blood Coagulation Factors
  • Cardiolipins
  • Lupus Coagulation Inhibitor
  • Procainamide